ReoPro (abciximab) to inhibit blood clotting
January 1996
You'll see more physicians using ReoPro (abciximab) to inhibit blood clotting.
This biotech anti-platelet drug came out earlier this year. It's for patients undergoing balloon angioplasty...to help keep the coronary artery open.
So far it's only approved for high-risk patients. But now there's evidence of an overwhelming benefit in reducing heart attack and death...even after routine cases of angioplasty.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote